Navigation Links
Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH

en compared to placebo, on either one of the two primary endpoints, change in pulmonary vascular resistance (PVR) and/or exercise capacity measured by six-minute walk distance after 16 weeks of treatment. The statistical analysis plan stipulated that, if either endpoint was significant, the study was to be considered positive. Other endpoints included change from baseline to week 16 in other hemodynamic parameters, Borg dyspnoea, WHO functional class, time to clinical worsening, NT-proBNP as well as quality of life assessments.

About Tracleer® in Pulmonary Arterial Hypertension (PAH) Tracleer® (bosentan), the first oral dual endothelin receptor antagonist, is approved for the treatment of pulmonary arterial hypertension (PAH) and made available by Actelion subsidiaries in the United States, the European Union, Japan, Australia, Canada, Switzerland and other markets worldwide 4. In clinical trials leading to the marketing approval of the drug, approximately 11% of PAH patients receiving Tracleer® experienced abnormal but reversible liver enzyme elevations. It is therefore important that patients undergo monthly liver monitoring. Due to the risk of birth defects, women who are pregnant, or of childbearing age that do not use a reliable method of contraception, must not take Tracleer® 4. Online information on pulmonary arterial hypertension (PAH): www.pah-info.com As part of an international PAH awareness campaign supported by Actelion Pharmaceuticals, www.pah-info.com has been created to provide healthcare professionals and patients with accurate and continuously updated information on PAH. The website contains information on symptoms, causes, diagnosis and current treatment options in separate sections for healthcare professionals and patients. The website is supported by high-quality resources such as a glossary, links to an extensiv
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Actelion Announces Positive Study with Bosentan Tracleer CTEPH
(Date:12/19/2014)... -- TODAY, AEGATE, the leader in medicine ... appointment of Peter Fox as Chief Technology ... Partner Officer. Peter has served as Development ... by Oracle in 2011. Prior to Datanomic, ... and subsequently Convergys, a world renowned billing system ...
(Date:12/19/2014)... Wash. , Dec. 19, 2014  Advanced ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that a Life ... has been awarded for which AMIC is the ... State University (WSU) for the proposal titled "Optimized ...
(Date:12/19/2014)... 2014 In today,s increasingly global marketplace ... to reflect the needs of a global marketplace ... the needs of key stakeholders while recognizing regional ... According to recent research by benchmarking firm, Best ... companies averaged more than $100,000 in annual spending ...
Breaking Medicine Technology:Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 2Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner 3Building a Best-in-Class Pharma Global Brand Website 2
... BOTHELL, Wash., Dec. 13, 2011  Cardiac Science Corporation, a ... and diagnostic cardiac monitoring devices , will supply ... For Life," a campaign to reduce deaths from sudden ... sporting clubs of Victoria, Australia. (Logo:  ...
... TUMWATER, Wash., Dec. 13, 2011  The Washington Health Care ... COMS Interactive , LLC (COMS or Clinical ... is in alignment with WHCA,s stated objective, which is ... provide long-term health care residents with the highest quality ...
Cached Medicine Technology:Australia's Sporting Clubs Select Cardiac Science AEDs 2Australia's Sporting Clubs Select Cardiac Science AEDs 3Australia's Sporting Clubs Select Cardiac Science AEDs 4WHCA Selects COMS Interactive as Affinity Partner 2WHCA Selects COMS Interactive as Affinity Partner 3
(Date:12/21/2014)... Theme and plugin developers ... plugin for Final Cut Pro X entitled ProMotion. , ... more with absolute ease.” Said Christiana Austin, CEO of ... needed to easily animate their media inside FCPX.” , ... users to animate pictures, videos, logos, and more with ...
(Date:12/20/2014)... BambooIndustry.com is a professional company ... business has recently shown its new engineered bamboo flooring ... bamboo flooring models. , BambooIndustry.com’s customers come from many ... more. According to the CEO of the company, the ... in the past few years, and the demand for ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its ... Christmas Sale, offering big discounts on all of its special ... idea to own a perfect wedding gown. If you have ... then come to LunaDress. Many different wedding dress styles and ... website now and enjoy the current special offer, up to ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The Doctor’s Office ... for the better part of a decade. They’ve treated ... a better, faster healthcare alternative to the Paramus ... announce three new additions to their staff of top-notch board ... Jill Zeiger MD. These new doctors will work ...
(Date:12/20/2014)... December 20, 2014 Recently, AngelWeddingDress.com has ... Discount ”) for the coming Christmas. In the promotion, ... 80% off. , “We have something special for the ... the holiday season. Moreover, our new collections of 2015 ... are offered now at greatly discounted prices. Visit our ...
Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
... recent report in Nature Medicine had said that the ... Encephalitis in India is due to lack of preparedness ... early vaccination programs//. The encephalitis infection is spread by ... in water logged paddy fields in the monsoon seasons. ...
... in the July issue of the journal Environmental Health ... levels and age of onset of natural menopause//. ... to reflect the rate of atrophy of the ovarian ... health implications because women with early menopause are at ...
... for its miraculous properties, Herceptin, the breast cancer wonder ... British medical journal questioned its effectiveness//. ,"The ... is profoundly misleading to suggest, even rhetorically, that the ... breast cancer," the editors of The Lancet wrote in ...
... role in female mortality, second only to infanticide in Asian ... student of economics at Harvard University//, found that infanticide may ... to female ratios in many Asian countries, reports science portal ... particularly China, where some 10 to 15 percent of the ...
... a multinational company to bring a cost effective vaccine ... Minister Anbumani Ramadoss //on the occasion of National Cancer ... cancer has been instrumental behind the initiative. ... mobilizing things to implement the plan in association with ...
... that reflecting on personal values can keep neuroendocrine and ... is implicated in the development //and progression of a ... and research on the self suggest that self-affirming activities ... study, published in the November issue of the journal ...
Cached Medicine News:Health News:Herceptin Not A ‘Wonder’ Drug, Says The Lanc 2Health News:Cervical Cancer Vaccine To Be Developed In India 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: